Variant report
Variant | nsv526391 |
---|---|
Chromosome Location | chr7:85047858-85055666 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr7:85055557-85056303 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr7:85053110-85053215 | MCF-7 | breast: | n/a | n/a |
3 | EP300 | chr7:85055633-85056190 | HepG2 | liver: | n/a | n/a |
4 | EP300 | chr7:85050386-85050549 | SK-N-SH_RA | brain: | n/a | n/a |
5 | EP300 | chr7:85055625-85056366 | HepG2 | liver: | n/a | n/a |
6 | FAM48A | chr7:85052008-85052110 | GM12878 | blood: | n/a | n/a |
7 | FOXA1 | chr7:85055639-85056241 | HepG2 | liver: | n/a | n/a |
8 | FOXA1 | chr7:85055602-85056216 | HepG2 | liver: | n/a | n/a |
9 | FOXA1 | chr7:85055623-85056241 | HepG2 | liver: | n/a | n/a |
10 | FOXA2 | chr7:85055665-85056226 | HepG2 | liver: | n/a | n/a |
11 | HNF4A | chr7:85055617-85056586 | HepG2 | liver: | n/a | n/a |
12 | JUN | chr7:85055465-85056230 | HepG2 | liver: | n/a | n/a |
13 | JUND | chr7:85055624-85056383 | HepG2 | liver: | n/a | n/a |
14 | MAFF | chr7:85053568-85053789 | HepG2 | liver: | n/a | n/a |
15 | MAFF | chr7:85051294-85051494 | HepG2 | liver: | n/a | n/a |
16 | MAFK | chr7:85053582-85053821 | HepG2 | liver: | n/a | n/a |
17 | MAFK | chr7:85053671-85053730 | HepG2 | liver: | n/a | n/a |
18 | MAZ | chr7:85055478-85056112 | HepG2 | liver: | n/a | n/a |
19 | MYBL2 | chr7:85055645-85056232 | HepG2 | liver: | n/a | n/a |
20 | MYC | chr7:85048381-85048425 | MCF-7 | breast: | n/a | n/a |
21 | NFYB | chr7:85051388-85051588 | GM12878 | blood: | n/a | n/a |
22 | POLR2A | chr7:85053751-85053933 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr7:85052805-85053232 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr7:85055598-85057330 | HepG2 | liver: | n/a | n/a |
25 | RFX5 | chr7:85055654-85056358 | HepG2 | liver: | n/a | n/a |
26 | SP1 | chr7:85055664-85056192 | HepG2 | liver: | n/a | n/a |
27 | STAT3 | chr7:85055638-85055730 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | TEAD4 | chr7:85055562-85056220 | HepG2 | liver: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GRM3-1 | chr7:85050438-85050574 | XLOC_006160 |
No data |
No data |
Variant related genes | Relation type |
---|---|
LINC00972 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537916734 | chr7:85048416-85048417 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs556239023 | chr7:85048424-85048425 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs146582244 | chr7:85049927-85049928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183627777 | chr7:85049955-85049956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138777490 | chr7:85049960-85049961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572035332 | chr7:85049965-85049966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545762183 | chr7:85050006-85050007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141342327 | chr7:85050021-85050022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368612418 | chr7:85050048-85050049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113111916 | chr7:85050067-85050068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576415251 | chr7:85050090-85050091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547481133 | chr7:85050179-85050180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7798105 | chr7:85050186-85050187 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs532963541 | chr7:85050190-85050191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2115744 | chr7:85050210-85050211 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs147007450 | chr7:85050247-85050248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530693726 | chr7:85050357-85050358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6465002 | chr7:85050389-85050390 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs548040708 | chr7:85050430-85050431 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs148072706 | chr7:85050508-85050509 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs185782582 | chr7:85050528-85050529 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs534476016 | chr7:85050533-85050534 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs190243959 | chr7:85050534-85050535 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs574659087 | chr7:85050558-85050559 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs182417349 | chr7:85050667-85050668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186724734 | chr7:85050729-85050730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192142439 | chr7:85050769-85050770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184088384 | chr7:85050779-85050780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188937193 | chr7:85050856-85050857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560062034 | chr7:85050877-85050878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200792068 | chr7:85050878-85050879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs397889911 | chr7:85050887-85050888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6970185 | chr7:85050934-85050935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs565132591 | chr7:85052806-85052807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113805361 | chr7:85052812-85052813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532370210 | chr7:85052823-85052824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550758514 | chr7:85052858-85052859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563002554 | chr7:85052880-85052881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530193564 | chr7:85052951-85052952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1975077 | chr7:85052975-85052976 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs113829945 | chr7:85053011-85053012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568632640 | chr7:85053037-85053038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548607233 | chr7:85053044-85053045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566742960 | chr7:85053058-85053059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534155885 | chr7:85053151-85053152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543488567 | chr7:85053162-85053163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552597013 | chr7:85053192-85053193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369001702 | chr7:85053250-85053251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538084625 | chr7:85053306-85053307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556318025 | chr7:85053330-85053331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Williams-beuren syndrome | 16826523 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:85049800-85051000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr7:85052800-85053600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr7:85055000-85056200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr7:85055000-85057200 | Enhancers | HepG2 | liver |
5 | chr7:85055600-85056000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr7:85055600-85056200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr7:85055600-85056400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |